• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哺乳动物26S和20S蛋白酶体从蛋白质产生的肽段大小。对理解降解机制和抗原呈递的意义。

The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation.

作者信息

Kisselev A F, Akopian T N, Woo K M, Goldberg A L

机构信息

Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

J Biol Chem. 1999 Feb 5;274(6):3363-71. doi: 10.1074/jbc.274.6.3363.

DOI:10.1074/jbc.274.6.3363
PMID:9920878
Abstract

Knowledge about the sizes of peptides generated by proteasomes during protein degradation is essential to fully understand their degradative mechanisms and the subsequent steps in protein turnover and generation of major histocompatibility complex class I antigenic peptides. We demonstrate here that 26 S and activated 20 S proteasomes from rabbit muscle degrade denatured, nonubiquitinated proteins in a highly processive fashion but generate different patterns of peptides (despite their containing identical proteolytic sites). With both enzymes, products range in length from 3 to 22 residues, and their abundance decreases with increasing length according to a log-normal distribution. Less than 15% of the products are the length of class I presented peptides (8 or 9 residues), and two-thirds are too short to function in antigen presentation. Surprisingly, these mammalian proteasomes, which contain two "chymotryptic," two "tryptic," and two "post-acidic" active sites, generate peptides with a similar size distribution as do archaeal 20 S proteasomes, which have 14 identical sites. Furthermore, inactivation of the "tryptic" sites altered the peptides produced without significantly affecting their size distribution. Therefore, this distribution is not determined by the number, specificity, or arrangement of the active sites (as proposed by the "molecular ruler" model); instead, we propose that proteolysis continues until products are small enough to diffuse out of the proteasomes.

摘要

了解蛋白酶体在蛋白质降解过程中产生的肽段大小,对于全面理解其降解机制以及蛋白质周转和主要组织相容性复合体I类抗原肽生成的后续步骤至关重要。我们在此证明,来自兔肌肉的26S和活化的20S蛋白酶体以高度连续的方式降解变性的、未泛素化的蛋白质,但产生不同的肽段模式(尽管它们含有相同的蛋白水解位点)。对于这两种酶,产物长度范围为3至22个残基,并且根据对数正态分布,其丰度随着长度增加而降低。不到15%的产物是I类呈递肽段的长度(8或9个残基),三分之二的产物太短而无法在抗原呈递中发挥作用。令人惊讶的是,这些含有两个“胰凝乳蛋白酶样”、两个“胰蛋白酶样”和两个“酸性后”活性位点的哺乳动物蛋白酶体,产生的肽段大小分布与具有14个相同位点的古细菌20S蛋白酶体相似。此外,“胰蛋白酶样”位点的失活改变了产生的肽段,但没有显著影响其大小分布。因此,这种分布不是由活性位点的数量、特异性或排列决定的(如“分子尺子”模型所提出的);相反,我们提出蛋白水解会持续进行,直到产物小到足以从蛋白酶体中扩散出来。

相似文献

1
The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation.哺乳动物26S和20S蛋白酶体从蛋白质产生的肽段大小。对理解降解机制和抗原呈递的意义。
J Biol Chem. 1999 Feb 5;274(6):3363-71. doi: 10.1074/jbc.274.6.3363.
2
Range of sizes of peptide products generated during degradation of different proteins by archaeal proteasomes.古细菌蛋白酶体降解不同蛋白质过程中产生的肽产物的大小范围。
J Biol Chem. 1998 Jan 23;273(4):1982-9. doi: 10.1074/jbc.273.4.1982.
3
Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes.γ-干扰素与主要组织相容性复合体(MHC)基因的表达可调节蛋白酶体对肽的水解作用。
Nature. 1993 Sep 16;365(6443):264-7. doi: 10.1038/365264a0.
4
Proteolysis and class I major histocompatibility complex antigen presentation.蛋白水解作用与I类主要组织相容性复合体抗原呈递
Immunol Rev. 1999 Dec;172:49-66. doi: 10.1111/j.1600-065x.1999.tb01355.x.
5
The cleavage preference of the proteasome governs the yield of antigenic peptides.蛋白酶体的切割偏好决定了抗原肽的产量。
J Exp Med. 1995 Dec 1;182(6):1865-70. doi: 10.1084/jem.182.6.1865.
6
[Proteasomes. Complex proteases lead to a new understanding of cellular regulation through proteolysis].[蛋白酶体。复杂的蛋白酶通过蛋白水解作用使人们对细胞调节有了新的认识]
Naturwissenschaften. 1995 Jun;82(6):257-68. doi: 10.1007/BF01134523.
7
Post-proteasomal antigen processing for major histocompatibility complex class I presentation.用于主要组织相容性复合体I类呈递的蛋白酶体后抗原加工。
Nat Immunol. 2004 Jul;5(7):670-7. doi: 10.1038/ni1089.
8
Antigen processing by the proteasome.蛋白酶体对抗原的处理
Nat Rev Mol Cell Biol. 2001 Mar;2(3):179-87. doi: 10.1038/35056572.
9
Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7.蛋白酶体的肽酶活性受到主要组织相容性复合体编码的LMP2和LMP7基因的差异调节。
Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9213-7. doi: 10.1073/pnas.91.20.9213.
10
Effects of major-histocompatibility-complex-encoded subunits on the peptidase and proteolytic activities of human 20S proteasomes. Cleavage of proteins and antigenic peptides.主要组织相容性复合体编码亚基对人20S蛋白酶体的肽酶和蛋白水解活性的影响。蛋白质和抗原肽的切割。
Eur J Biochem. 1996 Jan 15;235(1-2):404-15. doi: 10.1111/j.1432-1033.1996.00404.x.

引用本文的文献

1
An Automated Workflow to Address Proteome Complexity and the Large Search Space Problem in Proteomics and HLA-I Immunopeptidomics.一种用于解决蛋白质组复杂性以及蛋白质组学和HLA-I免疫肽组学中大型搜索空间问题的自动化工作流程。
Mol Cell Proteomics. 2025 Jul 21;24(9):101039. doi: 10.1016/j.mcpro.2025.101039.
2
Proteasome-derived peptides: separating the trash from the recycling.蛋白酶体衍生肽:区分垃圾与回收物。
Trends Biochem Sci. 2025 Jul 12. doi: 10.1016/j.tibs.2025.06.007.
3
Not Just PA28γ: What We Know About the Role of PA28αβ in Carcinogenesis.
不仅仅是PA28γ:我们对PA28αβ在致癌作用中的作用的了解。
Biomolecules. 2025 Jun 16;15(6):880. doi: 10.3390/biom15060880.
4
Proteasome caspase-like activity regulates stress granules and proteasome condensates.蛋白酶体半胱天冬酶样活性调节应激颗粒和蛋白酶体凝聚物。
Front Cell Dev Biol. 2025 Jun 5;13:1570499. doi: 10.3389/fcell.2025.1570499. eCollection 2025.
5
ERAP1 Activity Modulates the Immunopeptidome but Also Affects the Proteome, Metabolism, and Stress Responses in Cancer Cells.内质网氨肽酶1(ERAP1)的活性调节免疫肽组,但也影响癌细胞中的蛋白质组、代谢和应激反应。
Mol Cell Proteomics. 2025 May;24(5):100964. doi: 10.1016/j.mcpro.2025.100964. Epub 2025 Apr 4.
6
Development of p300-targeting degraders with enhanced selectivity and onset of degradation.具有增强选择性和降解起始效果的p300靶向降解剂的开发。
RSC Med Chem. 2025 Mar 3;16(5):2049-2060. doi: 10.1039/d4md00969j. eCollection 2025 May 22.
7
Cell-autonomous innate immunity by proteasome-derived defence peptides.蛋白酶体衍生防御肽介导的细胞自主固有免疫
Nature. 2025 Mar;639(8056):1032-1041. doi: 10.1038/s41586-025-08615-w. Epub 2025 Mar 5.
8
Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease.不依赖泛素的蛋白酶体降解机制及其在年龄相关性神经退行性疾病中的作用。
Front Cell Dev Biol. 2025 Feb 7;12:1531797. doi: 10.3389/fcell.2024.1531797. eCollection 2024.
9
Molecular Insights into the Regulation of GNPTAB by TMEM251.TMEM251对GNPTAB调控的分子机制洞察
bioRxiv. 2024 Dec 5:2024.12.05.627003. doi: 10.1101/2024.12.05.627003.
10
Hemoglobin α-derived peptides VD-hemopressin (α) and RVD-hemopressin (α) are involved in electroacupuncture inhibition of chronic pain.血红蛋白α衍生肽VD-血红蛋白加压素(α)和RVD-血红蛋白加压素(α)参与电针抑制慢性疼痛。
Front Pharmacol. 2024 Oct 1;15:1439448. doi: 10.3389/fphar.2024.1439448. eCollection 2024.